Search results
Results From The WOW.Com Content Network
Dogs which are heterozygous (that is, which have one functioning ABCB1 gene, and one non-functioning gene) are less sensitive to acepromazine than dogs which are homozygous (that is, which have two copies of the mutant gene). 75% of Collies carry the mutated ABCB1 gene, as do 50% of Australian Shepherds. Other affected breeds include: Border ...
The Australian Shepherd is one of the more commonly affected breeds for an autosomal recessive mutation of the MDR1 gene. [11] This mutation causes greater sensitivity to certain drugs at normally safe doses, including ivermectin. [12] A test is available to determine if a particular dog carries the mutated gene. [13]
Some collie breeds (especially the Rough Collie, Smooth Collie, and the Australian Shepherd) are affected by a genetic defect, a mutation within the MDR1 gene, [8] formerly known as "ivermectin sensitivity", but now known to cause lowered tolerance to a wide variety of different veterinary drugs. [9]
I think that the Australian Shepherd was spot on with its assessment of humans! Sundays for Dogs had the perfect caption for the video, too. "10/10 dogs agree - humans are overrated!" As a new dog ...
Ember is an adorable Australian Shepherd, and we all know that those are busy dogs! Her mom shared a fun, inexpensive DIY enrichment activity that she made for her, and I can't wait to make my dog ...
Hypertrophic Osteodystrophy (HOD) is a bone disease that occurs most often in fast-growing large and giant breed dogs; however, it also affects medium breed animals like the Australian Shepherd. The disorder is sometimes referred to as metaphyseal osteopathy, and typically first presents between the ages of 2 and 7 months. [1]
That's why dog owner Ava brought her Australian Shepherd, Koda, to a farm where he could try herding sheep! To her credit, it's a fantastic idea, but Koda's reaction to meeting the sheep on June 3 ...
Drug intolerance or drug sensitivity refers to an inability to tolerate the adverse effects of a medication, generally at therapeutic or subtherapeutic doses. Conversely, a patient is said to be "tolerating" a drug when they can tolerate its adverse effects.